HRT Financial’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-22,083
Closed -$7.19M – 3347
2024
Q1
$7.19M Buy
+22,083
New +$5.42M 0.04% 187
2023
Q3
– Sell
-140,374
Closed -$40.1M – 3303
2023
Q2
$40.1M Buy
+140,374
New +$39M 0.37% 29
2023
Q1
– Sell
-1,992
Closed -$409K – 3378
2022
Q4
$409K Buy
+1,992
New +$504K 0.01% 1555
2022
Q1
– Sell
-18,540
Closed -$3.31M – 4057
2021
Q4
$3.31M Buy
+18,540
New +$3.66M 0.02% 426

Other funds holding SWAV

HRT Financial's SWAV Position: Q2 2024 in Review

HRT Financial sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 22,083 shares — an estimated $7.19M sold.

HRT Financial first reported a position in SWAV in Q4 2021 and held it in 4 quarters. The position peaked at $40.1M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • HRT Financial reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 22,083 Shockwave Medical shares in Q2 2024, an estimated $7.19M.
  • HRT Financial first reported a position in Shockwave Medical in Q4 2021 and held it in 4 quarters.
  • HRT Financial's Shockwave Medical position peaked at $40.1M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.